Correlation Between Purple Biotech and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Purple Biotech and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Purple Biotech and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Purple Biotech and Champions Oncology, you can compare the effects of market volatilities on Purple Biotech and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Purple Biotech with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Purple Biotech and Champions Oncology.
Diversification Opportunities for Purple Biotech and Champions Oncology
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Purple and Champions is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Purple Biotech and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Purple Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Purple Biotech are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Purple Biotech i.e., Purple Biotech and Champions Oncology go up and down completely randomly.
Pair Corralation between Purple Biotech and Champions Oncology
Given the investment horizon of 90 days Purple Biotech is expected to under-perform the Champions Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Purple Biotech is 1.23 times less risky than Champions Oncology. The stock trades about -0.04 of its potential returns per unit of risk. The Champions Oncology is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest 787.00 in Champions Oncology on October 25, 2024 and sell it today you would earn a total of 334.00 from holding Champions Oncology or generate 42.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Purple Biotech vs. Champions Oncology
Performance |
| Timeline |
| Purple Biotech |
| Champions Oncology |
Purple Biotech and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Purple Biotech and Champions Oncology
The main advantage of trading using opposite Purple Biotech and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Purple Biotech position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |